Market Closed -
Sao Paulo
04:07:54 2024-03-28 pm EDT
5-day change
1st Jan Change
15
BRL
-0.92%
-1.32%
-16.85%
Sales 2024 *
7.81B
1.56B
Sales 2025 *
8.4B
1.68B
Capitalization
8.18B
1.63B
Net income 2024 *
616M
123M
Net income 2025 *
790M
158M
EV / Sales 2024 *
1.49
x
Net Debt
2024
*
3.44B
686M
Net Debt
2025
*
3.07B
611M
EV / Sales 2025 *
1.34
x P/E ratio 2024 *
13.7
x
P/E ratio 2025 *
10.5
x
Employees
27,300
Yield 2024 *
2.27%
Yield 2025 *
5.18%
Free-Float
44.29%
Duration
1 day 1 week 1 month 3 months 6 months 1 year 5 years 10 years
Period
5 minutes 15 minutes 30 minutes 1 hour 1 day 1 week 1 month 1 year
Style
CandleStick End-of-day OHLC Mountain
Dynamic Chart
Transcript : Fleury S.A., Q4 2023 Earnings Call, Mar 08, 2024
Mar. 08
Fleury S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Mar. 07
CI
Fleury S.A. Reports Earnings Results for the Full Year Ended December 31, 2023
Mar. 06
CI
Fleury S.A Seeks Inorganic Growth
Nov. 10
CI
Transcript : Fleury S.A., Q3 2023 Earnings Call, Nov 10, 2023
Nov. 10
Fleury S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Nov. 08
CI
Fleury Seeks Inorganic Growth
23-08-04
CI
Transcript : Fleury S.A., Q2 2023 Earnings Call, Aug 04, 2023
23-08-04
Fleury S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
23-08-02
CI
Transcript : Fleury S.A., Q1 2023 Earnings Call, May 05, 2023
23-05-05
Fleury S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023
23-05-03
CI
Fleury S.A. completed the acquisition of Instituto Hermes Pardini S.A. from Pardini family and others.
23-04-27
CI
Transcript : Fleury S.A., Q4 2022 Earnings Call, Mar 17, 2023
23-03-17
Fleury S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022
23-03-16
CI
Transcript : Fleury S.A., Q3 2022 Earnings Call, Nov 04, 2022
22-11-04
More news
1 day -0.92%
1 week -1.32%
Current month -5.72%
1 month -5.72%
3 months -16.85%
6 months -0.86%
Current year -16.85%
More quotes
Managers
Title Age Since
Chief Executive Officer
54
00-12-31
Director of Finance/CFO
63
21-07-22
Chief Tech/Sci/R&D Officer
48
06-12-31
Members of the board
Title Age Since
Director/Board Member
72
-
Director/Board Member
78
13-04-08
Director/Board Member
57
21-04-29
More insiders
Date
Price
Change
Volume
24-03-28
15
-0.92%
2,478,600
24-03-27
15.14
+1.07%
3,084,400
24-03-26
14.98
-0.07%
2,608,800
24-03-25
14.99
+0.07%
2,215,900
24-03-22
14.98
-1.45%
2,699,700
Delayed Quote
Sao Paulo, March 28, 2024 at 04:07 pm EDT
More quotes
Fleury S.A. specializes in clinical diagnosis, treatment and analysis services.
At the end of 2018, the group operated a network of 187 patient care centers and 23 hospital centers under Fleury, Weinmann, Clínica Felipe Mattoso, a +, Labs a + and Diagnoson a + brands.
More about the company
Average target price
19.9
BRL
Spread / Average Target
+32.67%
Consensus
1st Jan change
Capi.
-16.85% 1.63B -8.32% 9.21B -9.54% 3.67B +39.95% 3.59B -4.12% 2.6B -12.21% 2.25B -2.84% 2.01B -25.37% 1.54B -7.98% 1.12B +2.71% 1.06B
Medical & Diagnostic Laboratories
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1